teaser
↓Article continues below this sponsored advert↓
↑Advertisement↑
Treatment with an angiotensin II receptor type I blocker (ARB) before and after electrical cardioversion does not reduce recurrence of atrial fibrillation (AF), results of a randomised, placebo-controlled trial indicate.
Patients with persistent AF are usually treated using a “rhythm-control” strategy with electrical cardioversion used to restore sinus rhythm, explained Dr Arnljot Tveit of Asker and B
